ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES
Introduction. Modern sport of higher achievements is inextricably linked with constant physical activity of high intensity, which ultimately leads to the formation of overstrain phenomena in the first place of the cardiovascular system. The problems of drug correction remain virtually unresolved whi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sumy State University
2020-10-01
|
| Series: | Східноукраїнський медичний журнал |
| Subjects: | |
| Online Access: | https://eumj.med.sumdu.edu.ua/index.php/journal/article/view/107 |
| _version_ | 1811218231624466432 |
|---|---|
| author | V. Klapchuk V. Bezugla Yu. Vinnichuk |
| author_facet | V. Klapchuk V. Bezugla Yu. Vinnichuk |
| author_sort | V. Klapchuk |
| collection | DOAJ |
| description | Introduction. Modern sport of higher achievements is inextricably linked with constant physical activity of high intensity, which ultimately leads to the formation of overstrain phenomena in the first place of the cardiovascular system. The problems of drug correction remain virtually unresolved which emphasizes the urgency of the creation and clinical implementation of non-prohibited metabolic drugs aimed for the athletes of high qualification.
The purpose. Determination of the role of Cardonat in the cardiomyopathy, treatment caused by chronic physical overload (CMPCPO) in athletes.
Materials and methods. The study involved 48 athletes (representatives of cyclic sports) with a diagnosis of CMPCPO who were randomized into 2 equivalent (n = 24) groups: the main group and the control group. Athletes of both groups from the moment of diagnosis reduced. The volume and intensity of training loads was reduced in athletes of both groups by 75%. Control group participants received only basic therapy (Panangin, Triovite in therapeutic doses) and placebo (capsule with starch). Athletes of the main group in addition to basic therapy used Cardonat, one capsule three times a day for 4 weeks. Comprehensive study of athletes before and after the course of treatment included the determination of anthropometric data, anamnesis, physical examination, blood pressure measurements, 12-channel electrocardiography (ECG), echocardiography (Echo) in a state of relative rest, determination of overall physical disability
Results. The results of a study of the effectiveness of Сardonat treatment in representatives of cyclic sports with cardiomyopathy due to chronic physical overload are presented. It was shown that the addition of the drug to the complex therapy of this category of athletes is accompanied by positive clinical and instrumental changes in the activity of the cardiovascular system. Consequently, under the influence of Cardonat, the percentage of athletes who had complaints of heart pain, heart palpitations, manifestations of asthenic syndrome, significantly decreased. Frequency of recording systolic murmur in the apex of the heart significantly reduced in 38% of the athletes in auscultation. According to the ECG in the dynamics of treatment, there is a significant improvement in the repolarization processes of the left ventricle (normalization of the ST segment and T-wave), a decrease of rhythm disturbance and athletes percentage with a tendency to tachycardia. On echocardiography more significant reverse remodeling of the left ventricle, regression of myocardial hypertrophy and improvement of diastolic function were observed compared with the results of the control group. According to the PWC170 test the level of physical performance is significantly increased.
Conclusions. The additional use of Cardonat in therapy is safe, expedient, pathogenetically justified and can be considered as an important reserve for providing pharmacological assistance to athletes with CMPCPO.
The use of Cardonat in complex therapy is safe, expedient, pathogenetically justified and can be considered as an important reserve for providing pharmacological assistance to athletes with CMPCPO. |
| first_indexed | 2024-04-12T07:07:36Z |
| format | Article |
| id | doaj.art-c5dbccd4cf334ac2a847d7e8d73eefd7 |
| institution | Directory Open Access Journal |
| issn | 2663-5909 2664-4231 |
| language | English |
| last_indexed | 2024-04-12T07:07:36Z |
| publishDate | 2020-10-01 |
| publisher | Sumy State University |
| record_format | Article |
| series | Східноукраїнський медичний журнал |
| spelling | doaj.art-c5dbccd4cf334ac2a847d7e8d73eefd72022-12-22T03:42:45ZengSumy State UniversityСхідноукраїнський медичний журнал2663-59092664-42312020-10-0164396–408396–408107ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETESV. Klapchuk0V. Bezugla1Yu. Vinnichuk2Zaporizhzhia National Technical University, Zaporizhzhia, UkraineUkrainian Medical Center of Sports Medicine of the MoH of Ukraine, Kyiv, UkraineNational University of Physical Education and Sports of Ukraine, Kyiv, UkraineIntroduction. Modern sport of higher achievements is inextricably linked with constant physical activity of high intensity, which ultimately leads to the formation of overstrain phenomena in the first place of the cardiovascular system. The problems of drug correction remain virtually unresolved which emphasizes the urgency of the creation and clinical implementation of non-prohibited metabolic drugs aimed for the athletes of high qualification. The purpose. Determination of the role of Cardonat in the cardiomyopathy, treatment caused by chronic physical overload (CMPCPO) in athletes. Materials and methods. The study involved 48 athletes (representatives of cyclic sports) with a diagnosis of CMPCPO who were randomized into 2 equivalent (n = 24) groups: the main group and the control group. Athletes of both groups from the moment of diagnosis reduced. The volume and intensity of training loads was reduced in athletes of both groups by 75%. Control group participants received only basic therapy (Panangin, Triovite in therapeutic doses) and placebo (capsule with starch). Athletes of the main group in addition to basic therapy used Cardonat, one capsule three times a day for 4 weeks. Comprehensive study of athletes before and after the course of treatment included the determination of anthropometric data, anamnesis, physical examination, blood pressure measurements, 12-channel electrocardiography (ECG), echocardiography (Echo) in a state of relative rest, determination of overall physical disability Results. The results of a study of the effectiveness of Сardonat treatment in representatives of cyclic sports with cardiomyopathy due to chronic physical overload are presented. It was shown that the addition of the drug to the complex therapy of this category of athletes is accompanied by positive clinical and instrumental changes in the activity of the cardiovascular system. Consequently, under the influence of Cardonat, the percentage of athletes who had complaints of heart pain, heart palpitations, manifestations of asthenic syndrome, significantly decreased. Frequency of recording systolic murmur in the apex of the heart significantly reduced in 38% of the athletes in auscultation. According to the ECG in the dynamics of treatment, there is a significant improvement in the repolarization processes of the left ventricle (normalization of the ST segment and T-wave), a decrease of rhythm disturbance and athletes percentage with a tendency to tachycardia. On echocardiography more significant reverse remodeling of the left ventricle, regression of myocardial hypertrophy and improvement of diastolic function were observed compared with the results of the control group. According to the PWC170 test the level of physical performance is significantly increased. Conclusions. The additional use of Cardonat in therapy is safe, expedient, pathogenetically justified and can be considered as an important reserve for providing pharmacological assistance to athletes with CMPCPO. The use of Cardonat in complex therapy is safe, expedient, pathogenetically justified and can be considered as an important reserve for providing pharmacological assistance to athletes with CMPCPO.https://eumj.med.sumdu.edu.ua/index.php/journal/article/view/107sport, cardonat, cardiovascular system of athletes, cardiomyopathy, chronic overstrain, electrocardiography, echocardiography, physical capacity |
| spellingShingle | V. Klapchuk V. Bezugla Yu. Vinnichuk ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES Східноукраїнський медичний журнал sport, cardonat, cardiovascular system of athletes, cardiomyopathy, chronic overstrain, electrocardiography, echocardiography, physical capacity |
| title | ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES |
| title_full | ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES |
| title_fullStr | ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES |
| title_full_unstemmed | ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES |
| title_short | ASSESSMENT OF CARDONAT EFFICIENCY IN CARDIOMYOPATHY TREATMENT AFTER PHYSICAL OVERLOAD IN ATHLETES |
| title_sort | assessment of cardonat efficiency in cardiomyopathy treatment after physical overload in athletes |
| topic | sport, cardonat, cardiovascular system of athletes, cardiomyopathy, chronic overstrain, electrocardiography, echocardiography, physical capacity |
| url | https://eumj.med.sumdu.edu.ua/index.php/journal/article/view/107 |
| work_keys_str_mv | AT vklapchuk assessmentofcardonatefficiencyincardiomyopathytreatmentafterphysicaloverloadinathletes AT vbezugla assessmentofcardonatefficiencyincardiomyopathytreatmentafterphysicaloverloadinathletes AT yuvinnichuk assessmentofcardonatefficiencyincardiomyopathytreatmentafterphysicaloverloadinathletes |